Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Apr 25, 10:23

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2025 Apr 23, 17:58

Vir Biotechnology (NASDAQ:VIR) Shares Up 5.5% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 Apr 20, 09:26

Vir Biotechnology, Inc. (NASDAQ:VIR) Short Interest Up 28.3% in March

Vir Biotechnology Inc
Webhose 2025 Apr 20, 08:36

Walleye Capital LLC Increases Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 20, 07:52

Renaissance Technologies LLC Buys 55,300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 10, 05:00

New Mpro inhibitors revealed in Vir Biotechnology patent | BioWorld

Vir Biotechnology Inc
Webhose 2025 Apr 09, 16:06

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year Low - Here's Why

Vir Biotechnology Inc
Webhose 2025 Apr 09, 13:43

Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple

Vir Biotechnology Inc
Webhose 2025 Apr 09, 11:13

ADAR1 Capital Management LLC Sells 255,118 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 09, 00:00

Hepatitis B Virus (HBV) Infection Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | ABNewswire

Vir Biotechnology Inc
Webhose 2025 Apr 06, 08:03

Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells $474,286.40 in Stock

Vir Biotechnology Inc
Webhose 2025 Apr 06, 07:35

Prudential Financial Inc. Sells 180,800 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 31, 13:42

Vir Biotechnology Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution

Vir Biotechnology Inc
Webhose 2025 Mar 31, 00:00

Authority Investment Dhabi Abu - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 Mar 30, 10:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:59

Artisan Partners Limited Partnership Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:26

WINTON GROUP Ltd Reduces Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 29, 00:52

Vir Biotechnology (NASDAQ:VIR) Reaches New 1-Year Low - Here's Why

Vir Biotechnology Inc
Webhose 2025 Mar 28, 12:24

Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company

Vir Biotechnology Inc
Webhose 2025 Mar 27, 08:41

Fox Run Management L.L.C. Takes $364,000 Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 27, 08:32

49,651 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Acquired by Fox Run Management L.L.C.

Vir Biotechnology Inc

VirBiotechnology News

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

2024 Dec 26, 16:00

Polygon price prediction 2025: What will polygons be worth in 2025?

Frances Wang 2024 Dec 25, 16:00

Basics of investing in the stock market: How does the stock market work?

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Frances Wang 2024 Dec 23, 16:00

What is the FTSE 250 index and how to invest in FTSE 250 stocks

Frances Wang 2024 Dec 22, 16:00

7 Risk Factors: What will cause stock market crash in 2025?

Frances Wang 2024 Dec 22, 16:00

Start investing in stocks: 3 quality stocks that you should know earlier

Latest news

Show more
Frances Wang 2024 Dec 29, 16:00

Stock market today: Most Asian stocks fell after US equities declined

Stocks
Frances Wang 2024 Dec 29, 16:00

MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024

Cryptocurrencies Stocks
Dyogenes Diniz 2024 Dec 29, 16:00

Morning Note: Key Levels & Data Driving the Last Monday of 2024

Forex Morning Note USD
Closing 2024
Dyogenes Diniz 2024 Dec 26, 17:00

Week ahead: Closing 2024 and First Economic data from 2025

Forex Indices
Tesla soars
Dyogenes Diniz 2024 Dec 26, 17:00

Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights

Forex Oil S&P 500
Frances Wang 2024 Dec 26, 16:00

Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness

Stocks
Frances Wang 2024 Dec 25, 16:00

Asian stock market today: most Asian stocks rise amid thin holiday trading

Stocks
Frances Wang 2024 Dec 25, 16:00

Stock market today: Nasdaq, S&P 500, Dow surge ahead of Christmas break

Stocks

Info

Spread

0.07

Spread (%)

1.1218 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

868422528

Shares Outstanding

138064000

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.83

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Feb 17, 16:00

Pi network price prediction 2025: Will Pi Network price go up or down?

Stocks
Frances Wang 2025 Jan 21, 16:00

What is the XRP price prediction for 2025: Will XRP reach $1000?

Crypto
Frances Wang 2024 Dec 29, 16:00

What is the USD DXY index and how does the DXY reflect the dollar's value?

Indices
Trustpilot
SettingsRequest history38.1.18PHP Version37.96msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
38.21ms
peak_memory
8MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
0 of 0
array:14 [ "cookie" => array:1 [ 0 => "mktv4_ip_override=es-es; XSRF-TOKEN=eyJpdiI6InI5dnhzU2N4SURRcHFHMXBKYmh0Q0E9PSIsInZhbHVlIjoiMUp4bUxkWHRNZUhkM2hXSEIvQUc5NTJvTksrblorMXBlSytsd291VlhJVFVINzloeDBFMW5XOVRGY2tyblBRT3VMU1BKUVBHWDV2bnZWQTk3Yno0WlRoZWJZekIwMFArcFhzUGNCZTk3dTgxV1Q3b00vZHFnQS80a3krb0ttdy8iLCJtYWMiOiI2YWY1ZjE5ZDc0ZmI1ZjlmODJkYWQxMjBkMTNmNWE2NzRiNjBhZjVhZTdjMTA2MGFiZjZjYTYwZmZmMzI3ZWQ1IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IjJ0MGpsSy9oNHpBNVVxeE9vUk9LUHc9PSIsInZhbHVlIjoiVEo3QkJSQzJsQmZES1hqNkRMZHJxVFlpcUFxcGFwdzRIc1dya0NoWThsT3BCQUZPRXhOZ3EycXg0ODhQMGlZdS91aDIrVVh4Ym9LOE4zZ0JRenhNNWlJOTdCMnVCVW0vY0hralVmb3lCT3paMUs0NmNaLzZJZExsY1JycFhMM0EiLCJtYWMiOiJiZDNkOTcxYzYxNjFiMTc3MzUxZWJjOTExOTM0MjQ0YjMyMGY1YTI1YzFjMjgzNGVjZTM0Y2E2NDk5Mzk0MTQwIiwidGFnIjoiIn0%3D; mktloc=eyJpdiI6IjNmNEM0ckFwVHdNUi8wVC9MY1c1TGc9PSIsInZhbHVlIjoiV3ovY2ZYQlYxMlBGb1Z4bGgvaGtnQm5Zb1QxNWhiK2h2SVlsdFQzL0lSVjNsR1BMVWhlRDdzeEFKRkpUMkVjciIsIm1hYyI6IjY3YTZiZjc4Njk3NjhkMzg0ZWNjMjQ5MDAyOWQ2ZDhjNzQzMTgzZGRmZmYwNmMwY2FmNDkxNDBlNjVlNDM1YTgiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fes-es%252Fmktv4_ip_override=es-es; XSRF-TOKEN=eyJpdiI6InI5dnhzU2N4SURRcHFHMXBKYmh0Q0E9PSIsInZhbHVlIjoiMUp4bUxkWHRNZUhkM2hXSEIvQUc5NTJvTksrblorMXBlSytsd291VlhJVFVINzloeDBF" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "empty" ] "sec-fetch-mode" => array:1 [ 0 => "cors" ] "sec-fetch-site" => array:1 [ 0 => "same-origin" ] "accept" => array:1 [ 0 => "*/*" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "web-qa.staging.markets.com" ] ]
request_cookies
0 of 0
array:5 [ "mktv4_ip_override" => null "XSRF-TOKEN" => "3PMe5KLvJdF9uJARL1ZEiBdSHxXFjFmvXCmdyUIg" "laravel_session" => "16w7o8itq8d1VSCgTk9r7fbzQYEh1RAxogGP1BFK" "mktloc" => "us,us" "intent_group" => null ]
response_headers
0 of 0
array:3 [ "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sat, 26 Apr 2025 01:57:35 GMT" ] "content-type" => array:1 [ 0 => "application/json" ] ]
session_attributes
0 of 0
array:4 [ "_token" => "3PMe5KLvJdF9uJARL1ZEiBdSHxXFjFmvXCmdyUIg" "PHPDEBUGBAR_STACK_DATA" => [] "_previous" => array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ] "_flash" => array:2 [ "old" => [] "new" => [] ] ]
    • Booting (17.18ms)time
    • Application (20.77ms)time
    • Routing (481μs)
    • 1 x Application (54.71%)
      20.77ms
      1 x Booting (45.26%)
      17.18ms
      1 x Routing (1.27%)
      481μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              3PMe5KLvJdF9uJARL1ZEiBdSHxXFjFmvXCmdyUIg
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-26 01:57:37GET/instrument/virbiotechnology/?override=19098
              #22025-04-26 01:57:35GET/csrf (ajax)
              #32025-04-26 01:57:35GET/params (ajax)